By F. Perry Wilson, MD, MSCE Welcome to Impact Factor, your weekly dose of commentary on a new medical study. I'm Dr F. Perry Wilson of the Yale School of Medicine If you took a random sample of 100 people from around the world, eight of them would have these...
By Esther Landhuis The antidepressant fluvoxamine (Luvox) may prevent hospitalization and death in outpatients with COVID-19, new research suggests. Results from the placebo-controlled, multisite, phase 3 TOGETHER trial showed that in COVID-19 outpatients at...
By Kathleen Doheny Soon after Merck announced on October 1 that it would ask federal regulators for emergency use authorization (EUA) for its auspicious new COVID-19 pill, the accolades began. Former US Food and Drug Administration (FDA) chief Scott...
Brenda Goodman, MA A large, real-world test of face masks in Bangladesh shows that masks work to reduce community spread of COVID-19. It also shows that surgical masks are more effective than cloth face coverings. The study, which was published ahead of peer...
Allison Shelley The CDC is setting up a new hub to watch for early warning signs of future infectious outbreaks, the agency announced Wednesday. Epidemiologists learn about emerging outbreaks by tracking information, and the quality of their analysis depends on their...
https://www.medscape.com/viewarticle/947197?src=mkm_covid_update_210310_MSCPEDIT&uac=135505MZ&impID=3240673&faf=1 Originally published by: Medscape Author: Heather Boerner Date: 3/10/2021 Categories: Prevention,Integrative Therapies,Treatment
https://www.medscape.com/viewarticle/947061?src=mkm_covid_update_210309_MSCPEDIT&uac=135505MZ&impID=3238585&faf=1 Originally published by: Medscape Author: Heather Boerner Date: 3/8/2021 Categories: Integrative Therapies,Treatment